PSA DENSITY IS A STRONGER PROGNOSTIC FACTOR THAN PSA IN LOCALLY ADVANCED PROSTATE CANCER: A MULTI-CENTER EXPERIENCE

被引：0
|
作者：
Chao-Yu, H.
Martin, S.
Paolo, G.
Alberto, B.
Giansilvio, M.
Bertrand, T.
Hein, V
Steven, J.
机构：
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2012年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：357 / 357
页数：1
相关论文
共 50 条
  • [41] End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation for prostate cancer.
    Tran, Phuoc T.
    Narang, Amol
    Ram, Ashwin
    Robertson, Scott P.
    He, Pei
    Griffith, Emiliy
    Singh, Harleen
    DeWeese, Tate
    Honig, Stephanie
    McNutt, Todd R.
    Song, Danny
    DeWeese, Theodore L.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [42] PSA KINETICS IN INITIAL ANDROGEN DEPRIVATION THERAPY IS A PROGNOSTIC FACTOR IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER
    Hamano, Itsuto
    Hatakeyama, Shingo
    Narita, Shintaro
    Takahashi, Masahiro
    Sakurai, Toshihiko
    Kawamura, Sadafumi
    Hoshi, Senji
    Ishida, Masanori
    Kawaguchi, Toshiaki
    Ishidoya, Shigeto
    Shimoda, Jiro
    Sato, Hiromi
    Mitsuzuka, Koji
    Tochigi, Tatsuo
    Tsuchiya, Norihiko
    Arai, Yoichi
    Habuchi, Tomonori
    Ohyama, Chikara
    JOURNAL OF UROLOGY, 2020, 203 : E123 - E123
  • [43] PROGNOSTIC-SIGNIFICANCE OF STAGE, GRADE, RACE, PRETREATMENT PSA, PSA HALF-LIFE, PROSTATE VOLUME AND PSA DENSITY IN PATIENTS UNDERGOING EXTERNAL-BEAM RADIOTHERAPY FOR LOCALIZED PROSTATE-CANCER - A LOGISTIC-REGRESSION ANALYSIS
    SWEENEY, PJ
    VIJAYAKUMAR, S
    BARNARD, J
    DONG, L
    AWAN, A
    WEICHSELBAUM, RR
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 : 283 - 284
  • [44] HDR-afterloading in locally advanced prostate cancer in an outpatient setting - experience of an interdisciplinary prostate center
    Spira, G
    Metz, J
    Muskalla, K
    Derakhshani, P
    Neubauer, S
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S114 - S114
  • [45] Abnormal p53 expression is a prognostic factor in locally advanced prostate cancer
    Nature Clinical Practice Oncology, 2008, 5 (2): : 66 - 66
  • [46] Complexed prostate specific antigen density is better than the other PSA derivatives for detection of prostate cancer in men with total PSA between 2.5 and 20 ng/ml:: Results of a prospective multicenter study
    Sözen, S
    Eskicorapci, S
    Küpelia, B
    Irkilata, L
    Altinel, M
    Özer, G
    Uygur, C
    Alkibay, T
    Özen, H
    EUROPEAN UROLOGY, 2005, 47 (03) : 302 - 307
  • [47] Defining the optimal PSA range for the maximal predictive efficacy of PSA density to detect prostate cancer on biopsy: Results from a multi-institutional and prospective contemporary cohort.
    Rai, Samarpit
    Pavan, Nicola
    Soodana-Prakash, Nachiketh
    Nahar, Bruno
    Dong, Yan
    Satyanarayana, Ramgopal
    Parekh, Dipen
    Punnen, Sanoj
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [48] Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy
    Atsushi Tomioka
    Nobumichi Tanaka
    Motokiyo Yoshikawa
    Makito Miyake
    Satoshi Anai
    Yoshitomo Chihara
    Eijiro Okajima
    Akihide Hirayama
    Yoshihiko Hirao
    Kiyohide Fujimoto
    BMC Cancer, 15
  • [49] Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy
    Tomioka, Atsushi
    Tanaka, Nobumichi
    Yoshikawa, Motokiyo
    Miyake, Makito
    Anai, Satoshi
    Chihara, Yoshitomo
    Okajima, Eijiro
    Hirayama, Akihide
    Hirao, Yoshihiko
    Fujimoto, Kiyohide
    BMC CANCER, 2015, 15
  • [50] End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer
    A K Narang
    J Trieu
    N Radwan
    A Ram
    S P Robertson
    P He
    C Gergis
    E Griffith
    H Singh
    T A DeWeese
    S Honig
    A Annadanam
    S Greco
    C DeVille
    T McNutt
    T L DeWeese
    D Y Song
    P T Tran
    Prostate Cancer and Prostatic Diseases, 2017, 20 : 203 - 209
12345